1. Horowitz JM, Kamel IR, Arif-Tiwari H, Asrani SK, Hindman NM, Kaur H, McNamara MM, Noto RB, Qayyum A, Lalani T (2017) ACR Appropriateness Criteria(®) Chronic Liver Disease. J Am Coll Radiol 14:S391-s405. https://doi.org/10.1016/j.jacr.2017.08.045
2. American College of Radiology Committee on LI-RADS® (2018) CT/MRI LI-RADS® v2018 CORE. https://www.acr.org/-/media/ACR/Files/RADS/LI-RADS/LI-RADS-2018-Core.pdf?%20la=en. Accessed 01 January 2021
3. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2012) GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. International Agency for Research on Cancer. globocan.iarc.fr. Accessed 01 January 2021
4. National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program (2009) SEER*Stat Database: Incidence-SEER Research Data 9 Registries. Accessed 01 January 2021
5. Wilson JM, Jungner YG (1968) Principles and practices of screening for disease. World Health Organization. https://apps.who.int/iris/handle/10665/37650. Accessed 01 January 2021